Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Roles of Farnesyl-Diphosphate Farnesyltransferase 1 in Tumour and Tumour Microenvironments
Nguyễn Thị Thu Hà, Chang Hoon Lee
Cells (2020) Vol. 9, Iss. 11, pp. 2352-2352
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Nanomedicines Targeting Metabolic Pathways in the Tumor Microenvironment: Future Perspectives and the Role of AI
Shuai Fan, Wenyu Wang, Wieqi Che, et al.
Metabolites (2025) Vol. 15, Iss. 3, pp. 201-201
Open Access | Times Cited: 2
Altered blood gene expression in the obesity-related type 2 diabetes cluster may be causally involved in lipid metabolism: a Mendelian randomisation study
Juliette A. de Klerk, Joline W. J. Beulens, Hailiang Mei, et al.
Diabetologia (2023) Vol. 66, Iss. 6, pp. 1057-1070
Open Access | Times Cited: 29
The Role of Cholesterol Metabolism and Its Regulation in Tumor Development
Yongmei Wu, Wenqian Song, Su Min, et al.
Cancer Medicine (2025) Vol. 14, Iss. 7
Open Access | Times Cited: 1
Crosstalk between cholesterol metabolism and psoriatic inflammation
Lingling Luo, Youming Guo, Lihao Chen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Enzymes in the Cholesterol Synthesis Pathway: Interactomics in the Cancer Context
П. В. Ершов, Leonid Kaluzhskiy, Yuri V. Mezentsev, et al.
Biomedicines (2021) Vol. 9, Iss. 8, pp. 895-895
Open Access | Times Cited: 35
Cholesterol-Lowering Phytochemicals: Targeting the Mevalonate Pathway for Anticancer Interventions
Kagiso Laka, Lilian Makgoo, Zukile Mbita
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 27
Raman spectroscopy biochemical characterisation of bladder cancer cisplatin resistance regulated by FDFT1: a review
M. Kanmalar, S.F. Abdul Sani, Nur Izzahtul Nabilla B. Kamri, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 22
Targeting of Mevalonate-Isoprenoid Pathway in Acute Myeloid Leukemia Cells by Bisphosphonate Drugs
Emanuela Chiarella, Clelia Nisticò, Anna Di Vito, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1146-1146
Open Access | Times Cited: 21
FDFT1 repression by piR-39980 prevents oncogenesis by regulating proliferation and apoptosis through hypoxia in tongue squamous cell carcinoma
Trisha Chattopadhyay, Bibekanand Mallick
Life Sciences (2023) Vol. 329, pp. 121954-121954
Closed Access | Times Cited: 13
Unveiling the Therapeutic Potential of Squalene Synthase: Deciphering Its Biochemical Mechanism, Disease Implications, and Intriguing Ties to Ferroptosis
David Figueredo Picón, Rachid Skouta
Cancers (2023) Vol. 15, Iss. 14, pp. 3731-3731
Open Access | Times Cited: 13
Exposure to Group B Streptococcus-induced chorioamnionitis alters the proteome of placental extracellular vesicles
Seline Vancolen, Mathilde Chevin, Bernard Robaire, et al.
Placenta (2025)
Closed Access
Candida albicans and colorectal cancer: A paradoxical role revealed through metabolite profiling and prognostic modeling
Hao-Ling Zhang, Rui Zhao, Lei Wang, et al.
World Journal of Clinical Oncology (2025) Vol. 16, Iss. 4
Closed Access
Uncovering Shared and Tissue-Specific Molecular Adaptations to Intermittent Fasting in Liver, Brain, and Muscle
Yibo Fan, Senuri De Silva, Nishat I. Tabassum, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Valproic acid induces ferroptosis and suppresses the proliferation of MDA-MB-231 cells by targeting FDFT1
Shuxian Zhang, Jiazhuo Liu, Yisong Yang, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Ubiquitin specific peptidase 32 acts as an oncogene in epithelial ovarian cancer by deubiquitylating farnesyl-diphosphate farnesyltransferase 1
Aya Nakae, Michiko Kodama, Toru Okamoto, et al.
Biochemical and Biophysical Research Communications (2021) Vol. 552, pp. 120-127
Closed Access | Times Cited: 21
Aberrant Cholesterol Metabolism in Ovarian Cancer: Identification of Novel Therapeutic Targets
Jiangnan He, Michelle K.Y. Siu, Hys Ngan, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 21
MiR-122-5p regulates the mevalonate pathway by targeting p53 in non-small cell lung cancer
Yu-Kun Zheng, Zhongshi Zhou, Guang‐Zhong Wang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 4
Open Access | Times Cited: 9
Novel estrogen-responsive genes (ERGs) for the evaluation of estrogenic activity
K. Nishi, Wenqiang Fu, Ryoiti Kiyama
PLoS ONE (2022) Vol. 17, Iss. 8, pp. e0273164-e0273164
Open Access | Times Cited: 13
Squalene synthase predicts poor prognosis in stage I‐III colon adenocarcinoma and synergizes squalene epoxidase to promote tumor progression
Huihong Jiang, Erjiang Tang, Ying Chen, et al.
Cancer Science (2021) Vol. 113, Iss. 3, pp. 971-985
Open Access | Times Cited: 18
Genome-wide profiling of dysregulated piRNAs and their target genes implicated in oncogenicity of tongue squamous cell carcinoma
Trisha Chattopadhyay, Pooja Gupta, Rojalin Nayak, et al.
Gene (2022) Vol. 849, pp. 146919-146919
Closed Access | Times Cited: 12
Multi-Omics Analysis Revealed a Significant Alteration of Critical Metabolic Pathways Due to Sorafenib-Resistance in Hep3B Cell Lines
Kholoud Y. I. Abushawish, Sameh S. M. Soliman, Alexander D. Giddey, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11975-11975
Open Access | Times Cited: 11
3β-Hydroxy-12-oleanen-27-oic Acid Exerts an Antiproliferative Effect on Human Colon Carcinoma HCT116 Cells via Targeting FDFT1
Jue Tu, Xiang Meng, Sheng Wang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 15020-15020
Open Access | Times Cited: 6
Identification of prognostic stemness biomarkers in colon adenocarcinoma drug resistance
Ziyue Li, Jierong Chen, Dandan Zhu, et al.
BMC Genomic Data (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Cellular Functions of Deubiquitinating Enzymes in Ovarian Adenocarcinoma
Yosuk Min, Hong‐Beom Park, Kwang‐Hyun Baek, et al.
Genes (2023) Vol. 14, Iss. 4, pp. 886-886
Open Access | Times Cited: 5
Farnesol brain transcriptomics in CNS inflammatory demyelination
William J. Doyle, Dana C. Walters, Xutong Shi, et al.
Clinical Immunology (2023) Vol. 255, pp. 109752-109752
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top